4//SEC Filing
Adams Brian 4
Accession 0001193125-25-195044
CIK 0001815442other
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:05 PM ET
Size
7.2 KB
Accession
0001193125-25-195044
Insider Transaction Report
Form 4
Adams Brian
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-09-03+105,000→ 105,000 totalExercise: $43.30Exp: 2035-09-02→ Common Stock (105,000 underlying) - Award
Common Stock
2025-09-03+52,500→ 52,500 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following September 3, 2025, subject to the reporting person's continued employment through each vesting date.
- [F2]Twenty-five percent (25%) of the shares underlying this stock option shall vest on September 3, 2026, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001636994
Filing Metadata
- Form type
- 4
- Filed
- Sep 2, 8:00 PM ET
- Accepted
- Sep 3, 5:05 PM ET
- Size
- 7.2 KB